Biogen Inc. (BIIB)
NASDAQ: BIIB · Real-Time Price · USD
208.46
-7.66 (-3.54%)
At close: Jul 6, 2026, 4:00 PM EDT
208.58
+0.12 (0.06%)
After-hours: Jul 6, 2026, 5:30 PM EDT

Biogen Stock Forecast

Stock Price Forecast

According to 36 analysts polled by S&P Global, Biogen stock has a consensus rating of "Buy" and an average price target of $220.28. The average 1-year stock price forecast is 5.67% higher than the current stock price, while the lowest is $150 (-28.04%) and the highest is $300 (+43.91%).

Price Target: $220.28 (+5.67%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$150$220.28$220$300
Change-28.04%+5.67%+5.54%+43.91%

Analyst Ratings

The average analyst rating for Biogen stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingJan '26Feb '26Mar '26Apr '26May '26Jun '26
Strong Buy141414171818
Buy211223
Hold182020161514
Sell000000
Strong Sell111111
Total353636363636

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
HSBC
HSBC
Sell
Maintains
$150$157
SellMaintains$150$157-24.69%Jul 6, 2026
H.C. Wainwright
H.C. Wainwright
Buy
Maintains
$228$237
BuyMaintains$228$237+13.69%Jul 2, 2026
Needham
Needham
Buy
Reiterates
$255$256
BuyReiterates$255$256+22.81%Jun 29, 2026
UBS
UBS
Buy
Maintains
$225
BuyMaintains$225+7.93%Jun 26, 2026
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Initiates
$206
BuyInitiates$206-1.18%Jun 22, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
10.05B
from 9.89B
Increased by 1.64%
Revenue Next Year
10.38B
from 10.05B
Increased by 3.27%
EPS This Year
13.32
from 15.28
Decreased by -12.80%
EPS Next Year
16.63
from 13.32
Increased by 24.77%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
10.98B10.17B9.84B9.68B9.89B10.05B
Revenue Growth
-18.32%-7.36%-3.32%-1.62%2.22%1.64%
Gross Profit
8.87B7.90B7.30B7.55B7.81B7.81B
Gross Margin
80.79%77.61%74.24%78.00%78.95%77.66%
Operating Income
3.44B3.02B1.90B2.61B2.85B2.81B
Net Income
1.56B3.05B1.16B1.63B1.29B1.52B
EPS
----15.2813.32
EPS Growth
-----7.23%-12.80%
Forward PE
13.9417.7017.549.7113.6615.64
Free Cash Flow
2.21B1.39B981.44M3.45B1.95B2.67B
No. Analysts
-----23
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High10.3B
Avg10.1B
Low9.6B

Revenue Growth

Revenue Growth202620272028
High
4.6%
Avg
1.6%
Low
-3.1%

EPS Forecast

EPS202620272028
High15.90
Avg13.32
Low-10.65

EPS Growth

EPS Growth202620272028
High
4.1%
Avg
-12.8%
Low-